tiprankstipranks
Advertisement
Advertisement

Genus Director Celia Baxter Increases Stake with Share Purchase

Story Highlights
  • Genus non-executive director Celia Baxter purchased 1,728 shares on 27 February 2026.
  • The notified director dealing slightly lifts insider ownership and may signal board confidence.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Genus Director Celia Baxter Increases Stake with Share Purchase

Claim 30% Off TipRanks

Genus plc ( (GB:GNS) ) has issued an update.

Genus plc has disclosed that non-executive director Celia Baxter bought 1,728 ordinary shares in the company on 27 February 2026 on the London Stock Exchange at an average price of £28.92865 per share. The purchase, classified as a director dealing under Market Abuse Regulation requirements, marginally increases insider ownership and may be viewed by investors as a signal of confidence in the company’s prospects.

The transaction was notified as an initial disclosure under Article 19 of the Market Abuse Regulation, which mandates prompt reporting of share dealings by persons discharging managerial responsibilities. While the stake acquired is relatively small in absolute terms, such purchases are often monitored by shareholders as indicators of alignment between board members and investor interests, as well as potential sentiment about future performance.

The most recent analyst rating on (GB:GNS) stock is a Hold with a £3110.00 price target. To see the full list of analyst forecasts on Genus plc stock, see the GB:GNS Stock Forecast page.

Spark’s Take on GB:GNS Stock

According to Spark, TipRanks’ AI Analyst, GB:GNS is a Neutral.

Genus plc’s overall stock score is driven by strong corporate events and solid financial performance. However, technical indicators suggest caution due to potential overbought conditions, and the high P/E ratio indicates possible overvaluation.

To see Spark’s full report on GB:GNS stock, click here.

More about Genus plc

Genus plc is a U.K.-listed company on the London Stock Exchange under the ticker GNS. It operates in the agricultural and biotechnology sector, focusing on animal genetics and breeding services for livestock producers worldwide. The company’s market focus is on improving productivity and efficiency in the global protein food chain through advanced breeding technologies.

Average Trading Volume: 170,257

Technical Sentiment Signal: Strong Buy

Current Market Cap: £2.1B

For an in-depth examination of GNS stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1